Shineco Secures $8.7 Million Technology Services Agreement and Reveals Partnership with BICC

Written by Emily J. Thompson, Senior Investment Analyst

SISI%

Updated: Sep 12 2025

0mins

Technology Services Contract: Shineco's subsidiary, Xi'an Dong'ao Health Management, has signed an $8.7M contract with Xinke Future Biotechnology for R&D on microalgae-derived extracellular vesicles technology, aiming to establish a comprehensive R&D system by 2026.
International Collaboration: A delegation from Singapore's BICC visited Dong'ao Health, leading to agreements on establishing a joint laboratory, a technology exchange mechanism, and integrating their networks to enhance clinical services in the biocellular field.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Shineco Secures $8.7 Million Technology Services Agreement and Reveals Partnership with BICC

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Rosen Law Firm Alerts on Sprouts Farmers Market Class Action Deadline

Rosen Law Firm Investigates Potential Securities Claims for America's Car-Mart Shareholders

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch